NCT00481728View on ClinicalTrials.gov

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Overactive Bladder

Interventions

DRUG

Tolterodine

Single dose per patient as determined by protocol.

PROCEDURE

Filling cystometry

This is a procedure.

PROCEDURE

Intravesical neurostimulation

This is a procedure.

Trial Locations (1)

CH- 8008

Pfizer Investigational Site, Zurich

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00481728 - Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate. | Biotech Hunter | Biotech Hunter